Literature DB >> 9164840

Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.

R B Crook1, A T Chang.   

Abstract

Atrionatriuretic peptide (ANP) lowers intraocular pressure in the eyes of humans and rabbits. We examined the effects of natriuretic peptides on cGMP formation and 125I-labelled-ANP binding to cultured cells derived from ciliary body epithelium, the site of aqueous humour formation in the eye. ANP, brain natriuretic peptide (BNP) and C-natriuretic peptide (CNP) at 1 microM stimulated cGMP formation 8.2(+/-1.2)-fold, 4.8(+/-0.6)-fold and 87.3(+/-12.1)-fold respectively. 125I-ANP bound to intact cells at a single site, with a dissociation constant KD=0.30+/-0.01 nM. BNP was as effective as ANP in displacing 125I-ANP, whereas CNP displaced label with a slightly higher IC50. 125I-ANP binding was displaced >95% by c-ANP, a specific ligand for natriuretic peptide C receptors (NPR-C). Cross-linking of 125I-ANP to cells labelled predominantly a protein of Mr 62000. These data suggest that 125I-ANP binding was primarily to NPR-C, whereas cGMP stimulation occurred primarily via natriuretic peptide B receptors (NPR-B). Vasopressin and histamine, both activators of the inositol phosphate/diacylglycerol phosphate pathway in non-pigmented ciliary epithelial cells, inhibited CNP stimulation of guanylate cyclase (NPR-B) and 125I-ANP binding (NPR-C) by 30-38%. Inhibition was mimicked by PMA, dioctanoylglycerol and phorbol didecanoate, whereas 4alpha phorbol didecanoate had no effect. Staurosporine and bisindolylmaleimide both blocked inhibition of 125I-ANP binding and cGMP formation by PMA. These results suggest that protein kinase C (PKC) down-regulates both NPR-B and NPR-C. PKC down-regulation of NPR-B varied inversely with CNP concentration. Inhibition by 1 microM PMA was 30.6(+/-4.0)% with 500 nM CNP, but 83.4(+/-8.8)% with 10 nM CNP, indicating that increasing CNP could partially overcome inhibition by PMA. Since extracellular CNP levels were not affected by PKC activation, the effect of PKC on NPR-B is best explained as a reduction in NPR-B affinity for CNP. NPR-C measured as 125I-ANP binding was likewise reduced 36.4(+/-5.1)% by exposure to PMA. In contrast with NPR-B inhibition, however, inhibition of NPR-C was due largely to a reduction in the number of receptor binding sites per cell rather than a reduction in receptor affinity for ligand. The data therefore suggest that both NPR-B and NPR-C are down-regulated by PKC, but that the mechanisms of down-regulation of the two receptors are different.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164840      PMCID: PMC1218400          DOI: 10.1042/bj3240049

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  Molecular biology of the natriuretic peptides and their receptors.

Authors:  K J Koller; D V Goeddel
Journal:  Circulation       Date:  1992-10       Impact factor: 29.690

2.  Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells.

Authors:  S Suga; K Nakao; I Kishimoto; K Hosoda; M Mukoyama; H Arai; G Shirakami; Y Ogawa; Y Komatsu; O Nakagawa
Journal:  Circ Res       Date:  1992-07       Impact factor: 17.367

Review 3.  Receptors of atrial natriuretic factor.

Authors:  T Maack
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

4.  Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP).

Authors:  K J Koller; D G Lowe; G L Bennett; N Minamino; K Kangawa; H Matsuo; D V Goeddel
Journal:  Science       Date:  1991-04-05       Impact factor: 47.728

5.  HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist, blocks ANP-induced renal responses through a specific interaction with guanylyl cyclase-linked receptors.

Authors:  Y Morishita; T Sano; H Kase; K Yamada; T Inagami; Y Matsuda
Journal:  Eur J Pharmacol       Date:  1992-03-12       Impact factor: 4.432

6.  Dynamics of atrial natriuretic factor-guanylate cyclase receptors and receptor-ligand complexes in cultured glomerular mesangial and renomedullary interstitial cells.

Authors:  G Y Koh; D R Nussenzveig; J Okolicany; D A Price; T Maack
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

7.  Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".

Authors:  S Suga; K Nakao; H Itoh; Y Komatsu; Y Ogawa; N Hama; H Imura
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

Authors:  D Toullec; P Pianetti; H Coste; P Bellevergue; T Grand-Perret; M Ajakane; V Baudet; P Boissin; E Boursier; F Loriolle
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

9.  Selective localization of C atrial natriuretic peptide receptors in the rat brain.

Authors:  S Zorad; K Tsutsumi; J M Saavedra
Journal:  Brain Res       Date:  1992-01-20       Impact factor: 3.252

10.  Effects of atrial natriuretic factor (ANF) on intraocular pressure and aqueous humor flow in the cynomolgus monkey.

Authors:  M Samuelsson-Almén; S F Nilsson; O Mäepea; A Bill
Journal:  Exp Eye Res       Date:  1991-08       Impact factor: 3.467

View more
  3 in total

Review 1.  Basis of chloride transport in ciliary epithelium.

Authors:  C W Do; M M Civan
Journal:  J Membr Biol       Date:  2004-07-01       Impact factor: 1.843

2.  Identification, regulation and anti-proliferative role of the NPR-C receptor in gastric epithelial cells.

Authors:  William R Gower; Gay M Carter; Quentin McAfee; Suzanne M Solivan
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

3.  Responses of sodium-hydrogen exchange to nitric oxide in porcine cultured nonpigmented ciliary epithelium.

Authors:  Mohammad Shahidullah; Amritlal Mandal; Nicholas A Delamere
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-15       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.